title: Risky business-the real life of the unresolved HCV therapy.
authors.affiliation: Serviço de Gastrenterologia, Centro Hospitalar do Algarve, Portimão, Portugal.
authors.forename: Alexandre Oliveira
authors.initials: AO
authors.lastname: Ferreira
authors.affiliation: Serviço de Gastrenterologia e Hepatologia - Hospital Santa Maria, Medical School of Lisbon, Lisbon, Portugal.
authors.forename: Rui Tato
authors.initials: RT
authors.lastname: Marinho
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy*; D008297:Male; D009842:Oligopeptides / Q000627:therapeutic use*; D011392:Proline / Q000031:analogs & derivatives*
chemical_list: D000998:Antiviral Agents; D009842:Oligopeptides; D011392:Proline